Unique Access Medical (UAM) is pleased to announce an exciting new venture that may interest those who are afflicted or know loved ones who are afflicted with Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig’s disease.
UAM is currently collaborating with Autologous Stem Cell treatment (ASC) to provide an innovative cellular treatment for those suffering from ALS. ASC is a regenerative treatment facilitator based in Australia that has lawfully conducted over 400 cellular treatments since 2012. Their innovative technology utilises the patients’ own blood to culture cells that are safe and effective without genetic manipulation.
UAM and ASC both believe that this cell product that has the ability to reconstitute neurons, can contribute to the health and improvement of ALS patients. UAM is happy to support this project to allow patients in need to gain access to an otherwise costly treatment.
UAM is now recruiting up to 10 patients afflicted with ALS to be treated in January 2018 on a first come first serve basis in Bangkok, Thailand. Feel free to contact us today to learn more about this opportunity and to secure a spot in the project.
Please contact us at [email protected] for more information and to arrange an online doctor consultation for free.
